Cefipime:

Among the advanced β-lactam antibiotics, CFP is briefly discussed in this dissertation. CFP, or one -{[(6R,7R) – 7 - [ (2Z) – 2 -(methoxyimino) acetamide-2-(2-amino -1,3 – thiazol – 4 - yl) [4.2.0] oct-2-en-3-yl]-2-carboxylato-8-oxo-5-thia-1-azabicyclo methyl-1-methylpyrrolidin-1-ium is an antibiotic belonging to the fourth family of cephalosporins (Fig. 1). Both Gram-positive and Gram-negative microorganisms, including those resistant to previous cephalosporins, are susceptible to its broad-spectrum antibacterial action. By attaching itself to penicillin-binding proteins (PBPs), CFP prevents the formation of bacterial cell walls, which results in cell lysis and death. It is appropriate for treating severe infections such pneumonia, urinary tract infections, and febrile neutropenia because it is especially efficient against Pseudomonas aeruginosa and stable against a variety of beta-lactamases. A selection of the most pertinent approaches was assembled in order to give a thorough overview of the bioanalytical use of liquid analytical chromatographic techniques coupled with mass spectrometry techniques (LCandMS).

Fig 1. Chemical Structure of Cefepime

Following a brief introduction to CFP and its therapeutic uses, this review provides a practical and regulatory overview of LC-MS and LC-MS/MS methods. For pharmacokinetic and pharmacodynamic research, sample extraction and plasma analysis are given particular attention because to the growing demand for accurate treatment monitoring⁷.

Importance of Analytical Estimation:

Analytical method development and validation (AMDV) are found critical processes in pharmaceutical industry and other scientific fields, ensuring that analytical techniques are found to be robust, reliable, and suitable for their intended purposes. This discussion highlights the importance of AMDV, its key components, and its implications for drug development and quality assurance^{8
- 10}.

Importance of Analytical Method Development

· Establishing Methodology

Analytical method development involves creating and refining techniques to accurately measure and analyze the components of a product. The purpose of developing new measurement techniques and improving previously established methods is to confirm that the measurement techniques chosen for given substance characteristics (e.g., identity, purity, strength, and stability) provide appropriate data for the analysis of the substances involved^{11, 12}.

· Regulatory Compliance

Validation of measurement techniques is not only considered a "good practice", but also a regulatory requirement. Regulatory agencies around the world require scientists to validate the analytical methods used in clinical trials, or when an analytical method will be used in the marketing authorization process, to validate that the analytical method is providing accurate, specific, precise, and robust measurements of the substance. The information is critical for obtaining drug approval as well as ensuring that the drug will be safe and effective for patient use¹³.

· Quality Assurance

Analytical method reliability is a direct contributor to product quality. When an analytical method is validated, the analytical method is established as producing reproducible data that meet predetermined criteria, which is critical for establishing quality assurance and control throughout the drug development process, including the evaluation of active pharmaceutical ingredients (APIs), excipients, and degradation products for safety and efficacy^14,15.

Key Components of Analytical Method Validation:

Importance of validating analytical methods, one must consider other important criteria:

· Accuracy: Refers to how close the calculated amount is to the actual amount found.

· Precision: It is defined as the extent of variability between repeat measurements made under identical conditions.

· LOD and LOQ: These are used when establishing the lowest concentration of analyte that can be detected or quantified accurately.

· System suitability testing: Verifies that the analytical instrument is operating properly before any testing or analysis takes place.

· Specificity: It relates to the method's ability to measure an analyte in the presence of other components.

· Robustness: It refers to the ability of a method to provide consistently acceptable results when subjected to small variations in conditions.

Steps in Method Development and Validation:

· Evaluating Current Techniques: Assess whether existing techniques are satisfactory or require development of new techniques.

· Performing Experiments: Carry out experiments to measure the effectiveness of newer or improved methods using established benchmarks.

· Utilizing Theoretical Frameworks: Use a theoretical framework to project anticipated results and analyze obtained data.

· Implementation in Real Life: Apply the techniques to actual samples to confirm their successful application.

Role in Pharmaceutical Industry:

To ensure that drugs have good quality, safety and are effective, the pharmaceutical sector relies on the creation and validation of sophisticated analytical techniques. These techniques are essential for drug development lifecycle actions from initial research through clinical trials and manufacture16. Below is a synopsis of the importance of these techniques as well as process and regulatory issues concerning their use¹⁶.

Regulatory Guidelines:

The validation of analytical methods and development is associated with guidelines established by various regulatory bodies.

These include:

· ICH Q2(R1): Provides guidelines for the validation of analytical procedures.

· FDA Guideline for Industry: Outlines expectations for Validation of analytical techniques and processes for pharmaceuticals and biologics.

These guidelines help standardize the validation process across the industry, ensuring that all pharmaceutical products meet safety and efficacy standards.

Analytical Techniques for Estimation:

Pharmaceutical Analysis Techniques in figure 2:

Chromatography

This method separates components in a moisture for analysis. It is widely used in pharmaceutical laboratories to identify and quantify drugs in formulations.

Spectroscopy

The molecules arrangement of components is examined implementing methods like NMR and UV- visible spectroscopy , which provides information regarding their concentration and structure .

Electrophoresis

Upon presence of an electric field this method is implemented is used to separates charged particles in a fluid. It is frequently implemented to analyse biomolecules alike nucleic acids and protein.

Titrimetric methods

These involve chemical reactions to determine the concentration of an analyte in a solution. They are often used for routine control in pharmaceuticals.

Electrochemical methods

These technique measure the electrical propertied of a solution to determine the concentration of specific ions or compounds, useful in various analytical applications

Fig 2. Different techniques for Analysis

The choice of analytical technique for estimation depends on the specific requirements of the project or analysis being conducted. Every approach has advantages and disadvantages, and frequently a mix of both of techniques is employed to achieve the most accurate and reliable results^{17, 18}. Understanding these techniques is crucial for effective project management, data analysis, and pharmaceutical research In Table 2 and 3.

Chromatographic Techniques

Table 2. Analysis between acyclovir and different drugs in different column with mobile phase

Sl. No	Stationay Phase (Column)	Mobile Phase (with ratio)	pH	Wavelength	Flowrate		Reference
ACYCLOVIR with CURCUMIN
1	C18 (250x4.6mm,5µm)	Mixture of acetonitrile,0.1%phosphoric acid, and methanol in the proportion of 50:40:10%v/v/v	-	254nm	0.8ml/min		19
ACYCLOVIR with HYDROCORTISONE
2	C18 (25x4.6 mm,5µm)	Mixture of Methanol: H₂O in the proportion of 80:20%v/v	3	254nm	1ml/min		20
ACYCLOVIR with LIDOCAINE
3	C18 (250x4.6 mm,5µm)	Mixture of (20mM ammonium acetate in H₂O and acetonitrile, in the proportion of 95:5%v/v/v	3.5	254nm		1ml/min	21
ACYCLOVIR SINGLE FORMULATION
4	C18 (250x4.6 mm,5µm)	Mixture of glacial acetic acid: acetonitrile Buffer in the proportion of 95:05% v/v	3.8	253nm		1ml/min	22
5	C18 (150x4.6 mm,5µm)	Mixture of H₂O and acetonitrile, in the proportion of 95:05%v/v	-	254nm		0.8 ml/min	23
6	C-18, 250mm x 4.6mm,5µ	Acetonitrile and pH-adjusted H₂O in the proportion of 20:80%v/v	6.74	254nm		0.5 ml/min	24
7	C18 (150x4.6 mm,3µm)	Mixture of H₂O and acetonitrile in the proportion of 05:95%v/v	-	253nm		1ml/min	25
8	C18 (75x4.6 mm,3.5µm)	Mixture of H₂O and in the proportion of 95:05%v/v	-	254nm		1.9 ml/min	26
9	C18 (150x3.9 mm,4µm)	Mixture of H₂O and acetonitrile in the proportion of 78:22%v/v	-	254nm		0.8 ml/min	27
10	C8 (4.6x1.5 mm,5µm)	Mixture of Acetonitrile and in the proportion of 70:30%v/v	3	254nm		0.5 ml/min	28
11	C18 (150x4.6 mm, 5µm)	Mixture of Acetonitrile: Methanol: Phosphate buffer: Acetonitrile in the proportion of 16:20:64%v/v./v	6	290nm		1ml/min	29
12	C18 (150x4.6 mm,5µm)	Mixture of phosphate buffer and Methanol in the proportion of 95:05%v/v	2.5	254nm		1ml/min	30
13	C18 (250x4.6 mm5µm)	Mixture of 5 mM ammonium acetate and Acetonitrile, in the proportion of 40:60%v/v	4	290nm		1ml/min	31
14	C18 (250x4.6 mm,5µm)	Mixture of HPLC-grade H₂O and Methanol in the proportion of 50:50%v/v	-	250nm		1ml/min	32

Applications of Analytical Tools in Drug Development:

Analytical tools play a crucial role in drug development, enhancing various stages from discovery to clinical trials. This overview highlights key applications of analytical methods and technologies in the pharmaceutical industry³⁵.

Applications of Analytical Tools in Drug Development

A. ML; Machine Learning and AI; Artificial Intelligence:

The implementation of artificial intelligence; AI and machine learning; ML algorithms in drug discovery and development procedures are expanding³⁶.

B. Analytical Method Development:

Analytical methods are vital for ensuring drug quality and safety.

C. Process Analytical Technology (PAT):

PAT is a methodology that enhances the quality and efficiency of pharmaceutical manufacturing.

D. Data Analytics:

Pharmaceutical companies leverage data analytics to inform various aspects of drug development.

E. Quality Control and Compliance:

Ensuring compliance with stringent regulatory standards is paramount in drug development.

Formulation Development:

Importance of Analytical Method Validation in Formulation Development

· Ensuring Drug Quality: The initial goal of any development program of pharmaceutical industries is to produce high-quality outcomes. Analytical method validation helps in understanding the composition of chemical compounds, which is crucial for the development of new drugs^37,38. This process allows for the identification of critical attributes that affect the drug's efficacy and safety.

· Regulatory Compliance: Regulatory authorities, such as the FDA and EMA, require that analytical methods be validated before they can be used in clinical trials or marketed. A poorly documented chemistry, manufacturing and controls (CMC) section can hinder of approval process in the clinical trials^{39- 41}. Thus, having validated analytical methods simplifies regulatory compliance and provides clear information about the drug's quality.

· Patient Safety: Patient safety is paramount in drug development. Analytical methods ensure that only safe compounds are used in clinical trials, which is essential for protecting human subjects during early-phase studies^42-44. The validation of these methods helps guarantee that the drugs administered are of the highest quality and efficacy.

Challenges and Future Perspectives:

A. Challenges:

Complexity of Drug Formulations:

Pharmaceutical formulations often consist of multiple active pharmaceutical ingredients (APIs) and excipients (inactive ingredients) and have a complex structure that adds difficulty when developing an analytical testing method. As a result of this complexity, the development of robust and sensitive analytical testing methods for measuring APIs (diarrhetic complexing factors (CFIs)) is not always guaranteed due to specificity or sensitivity issues^45-47.

Regulatory Compliance:

Adhering to required regulations (e.g., FDA and ICH) is important for establishing a safe and effective analytical testing method for measuring APIs; therefore, the regulatory landscape is continuously evolving, which requires an ongoing commitment to develop and maintain compliant analytical testing methods and consumes substantial resource time to achieve compliance.

Method Transfer and Validation:

Method transfers from research and development (RandD) laboratories to quality control (QC) laboratories can contribute to variability in method performance between laboratories; therefore, it is necessary to ensure that analytical testing methods demonstrate the same level of performance regardless of the location of the analytical testing, which is often difficult to achieve and requires extensive validation, typically leading to time-consuming and costly analytical testing method validation processes⁴⁸.

Technological Limitations:

Improvements in instrument capabilities (e.g., ultra-high performance liquid chromatography [UHPLC] and mass spectrometry [MS]) and enhancements to analytical testing methodology have provided laboratories with improved opportunities to perform analytical testing; however, compared with traditional analytical testing methodologies, there are still limitations regarding the sensitivity and specificity of these upgraded methodologies when validating for routine usage in complex biological matrices, and as a result, low levels of impurities and/or degradation products in pharmaceutical products may not be detected⁴⁹.

Sample Preparation Challenges:

Having an effective method for preparing samples to reduce their effect on other substances while recovering your targeted substance is very important. If you don’t prepare your sample correctly, you won’t get accurate data and therefore will have to go back and change your method to get new results^50,51.

B. Future Perspectives:

Integration of Advanced Technologies:

Future advancements in analytical chemistry may incorporate innovative technology such as AI and machine learning. The use of these technologies should improve the productivity of developing new analytical methods, enable faster evaluations of data and increase predictive capability of methods⁵².

Focus on Robustness and Flexibility:

Analytical chemists will continue to place increased emphasis on building robust methods that are capable of handling changes in sample composition and changes in the analytical environment. Analytical chemists will need to use systematic methods for assessing the robustness of their methods such as using design of experiments (DOE) to identify how the various parameters contribute to or affect the robustness of the method^53,54.

Regulatory Evolution:

As regulatory agencies continue to develop more stringent guidelines, analytical chemists must continually educate themselves on and update their methods to adhere to new regulations. There will also be a focus on validating analytical methods for biopharmaceuticals because biopharmaceuticals typically have a different set of requirements than traditional small molecule drugs^55,
56.

Collaboration across Disciplines:

A greater degree of communication and collaboration between analytical chemists, formulation scientists and regulatory affairs specialist will be necessary to develop more compliant and effective analytical methods that are consistent with the comprehensive strategy for drug development^57-60.

Sustainability Considerations:

The future of the development of analytical methods will primarily include a focus on sustainability. This will include minimizing both waste and energy use in the analytical process. It also reflects the larger trend of environmentally responsible drug development within the greater pharmaceutical industry.

CONCLUSION:

Biological matrices and instability in the clinical formulation of pharmaceutical drugs under certain conditions make the development and validation of different analytical techniques for these drugs problematic. If promising developments continue, these processes will experience improved accuracy, efficiency and regulatory compliance. As various techniques in liquid chromatography and mass spectrometry (LCandMS) technology develop further for improved sample preparation methods, researchers, physicians and regulatory bodies will need to collaborate to overcome present-day barriers, and assure the continued accurate therapeutic monitoring and quality assurance of this very important class of drugs, namely broad-spectrum antibiotics.

ABERRATION:

CFP: Cefipime

VZV: varicella-zoster virus

HSV: herpes simplex virus

LC and MS: liquid chromatographic techniques coupled with mass spectrometry

AMDV: Analytical method development and validation

LOD: Limit of Detection

LOQ: Limit of Quantification

ML: Machine Learning

AI: Artificial Intelligence

CMC: chemistry, manufacturing, and controls

APIs: active pharmaceutical ingredients

RandD: research and development

QC: quality control

CONFLICT OF INTERESTS:

The authors admitted that there is no conflict of interest between the authors.

ACKNOWLEDGEMENT:

The authors are thankful to Centurion University of Technology and Management for providing the necessary infrastructure for the research work. We are also thankful to our society for its positive attitude.

REFERENCE:

1. Kausar S. Khan FS. Rehman MIM. Akram M. Riaz M. Rasool G. Khan AH. Saleem I. Shamim S. Malik A. A review: Mechanism of action of antiviral drugs. International Journal of Immunopathology and Pharmacology. 2021: 35:1–12. doi: 10.1177/20587384211002621.

2. Kirtimaya Mishra. Budumuru Padmasri. Swetha Vegesna. Asra Jabeen. Abhilash Dash. Satyam Kumar. Diptimayee Jena. Chemometric Assisted UV-Spectrophotometric Quantification of Cefaclor in Suspension Dosage Form. International Journal of Pharmaceutical Quality Assurance. 2023: 14(3):734-739.

3. Seley-Radtke KL. Yates MK. The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold, Antiviral Research. 2018: 154: 66–86. doi: 10.1016/j.antiviral.2018.04.004.

4. Whitley RJ. Gnann JW Jr. Acyclovir: a decade later, New England Journal of Medicine. 1992: 327(11): 782-9. doi: 10.1056/NEJM199209103271108.

5. Shivani Sharma. Swapnil Goyal. Kalindi Chauhan. A review on analytical method development and validation. International Journal of Applied Pharmaceutics. 2018: 10(6): 8-15. doi: http://dx.doi.org/10.22159/ijap.2018v10i6.28279.

6. Ramole Rina. Mohini Baile. Ashish Jain. A Review: Analytical Method Development and Validation, Systematic Reviews in Pharmacy. 2021: 12(8): 450-454

7. Kirtimaya Mishra. Swagatam Sahoo. Purnima Mahato. Nilesh Kumar Singh. Diptimayee Jena. Advancing Azelnidipine Dosage Form Analysis: A Quality by Design Guided Journey with Green Chemistry Innovations. African Journal of Biological Sciences. (2024): 6(11): 423-434.

8. P. Ravisankar. S. Gowthami1. G. Devlala Rao. A review on analytical method development. Indian Journal of Research in Pharmacy and Biotechnology. 2014: 2(3): 1183-1195

9. Kirtimaya Mishra. Diptimayee Jena. Nakhetra Bhusan Nayak. Asra Jabeen. Abhilash Dash. Subhashree Sahoo. Diptimayee Jena. Advanced, Simple, Sensitive, Selective Reverse Phase Liquid Chromatography Technique for The Quantitative Determination of Ritonavir and Lopinavir in In-House Dosage Form. Bulletin of Environment, Pharmacology and Life Sciences. 2023: 12(11): 217-222.

10. Sharma S. Singh N. Ankalgi AD. Rana A. Ashawat MS. Modern Trends in Analytical Techniques for Method Development and Validation of Pharmaceuticals: A Review. Journal of Drug Delivery and Therapeutics. 2021: 11(1-s): 121-130 doi: http://dx.doi.org/10.22270/jddt.v11i1-s.4515

11. Thorsten Verch. Cristiana Campa. Cyrille C. Chéry. Ruth Frenkel. Timothy Graul. Nomalie Jaya. Bassam Nakhle. Jeremy Springall. Jason Starkey. Jette Wypych. Todd Ranheim. Analytical Quality by Design, Life Cycle Management, and Method Control, The American Association of Pharmaceutical Scientists. 2022: 24(1): 34. doi: 10.1208/s12248-022-00685-2.

12. Lal. Basant and Kapoor. Devesh and Jaimini. Manish. A review on analytical method validation and its regulatory perspectives. Journal of Drug Delivery and Therapeutics. 2019: 9: 501-506. doi:10.22270/jddt. v9i2.2403.

13. Masoom Raza Siddiqui. Zeid A. AlOthman. Nafisur Rahman. Analytical techniques in pharmaceutical analysis: A review. Arabian Journal of Chemistry. 2017: 10: S1409–S1421

14. Kim EJ. Kim JH. Kim MS. Jeong SH. Choi DH. Process Analytical Technology Tools for Monitoring Pharmaceutical Unit Operations: A Control Strategy for Continuous Process Verification. Pharmaceutics. 2021: 13(6): 919. doi: 10.3390/pharmaceutics13060919

15. Vaishali M. Badgujar. Pritam S. Jain. Advances In Analytical Techniques, Method Development, And Validation Protocols In Pharmaceutical Research, International Journal of Pharmaceutical Sciences. 2024: 2(3): 728-738. doi: https://doi.org/10.5281/zenodo.10845542

16. Mishra P. Pandey CM. Singh U. Keshri A. Sabaretnam M. Selection of appropriate statistical methods for data analysis. Annals of cardiac anaesthesi. 2019: 22: 297-301.

17. Munteanu IG. Apetrei C. Analytical Methods Used in Determining Antioxidant Activity: A Review. International Journal of Molecular Sciences. 2021: 22(7): 3380. doi: 10.3390/ijms22073380.

18. Ghulam A. Shabir. Validation of high-performance liquid chromatography methods for pharmaceutical analysis: Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization, Journal of Chromatography A. 2003: 987(1–2): 57-66

19. Reolon J. Brustolin M. Haas SE. Bender EA. Malesuik MD. Colome LM. Development and validation of high-performance liquid chromatography method for the simultaneous determination of acyclovir and curcumin in polymeric microparticles. Journal of Applied Pharmaceutical Science. 2018: 8(1): 136-141.

20. Naik RM. Ahmed S. Reddy GNK. RP-HPLC Method Development and Validation for Simultaneous Estimation of Hydrocortisone and Acyclovir in Pharmaceutical Dosage Forms. American Journal of Pharmacy and Health Research. 2018: 6(6): 5-18.

21. Mulabagal V. Annaji M. Kurapati S. Dash RP. Srinivas NR. Tiwari AK. Babu RJ. Stability-indicating HPLC method for acyclovir and lidocaine in topical formulations. Biomedical Chromatography. 2020: 34(3): e4751. doi: 10.1002/bmc.4751. Epub 2020 Jan 12.

22. KumarYP. Sreedhar C. Rao ST. Akkamma HG. Reddy GB. Shrestha DM. New Analytical Method Development and Validation of Acyclovir by Rp-Hplc Method. Unique Journal of Pharmaceutical and Biological Sciences. 2016: 4(2): 20-26.

23. Stulzer HK. Tagliari MP. Murakami FS. Silva MAS. Laranjeira MCM. Development and Validation of an RP-HPLC Method to Quantitate Acyclovir in Cross-Linked Chitosan Microspheres Produced by Spray Drying. Journal of Chromatographic Science. 2008: 46: 496-500.

24. Ghumre SV. Jadhav VM. Kadam VJ. High Pressure Liquid Chromatographic Method Development and Validation for Estimation of Acyclovir in Bulk and Marketed Formulation. International Journal of Pharmaceutical Sciences and Research. 2016: 7(5): 2194-2200.

25. Hamdi A. Fegast R. Berka B. Clarck BJ. Stability test of Acyclovir at severe conditions. Asian Journal of Chemistry. 2005: 17(4): 2699-2704.

26. Quadeib BTA. A simple RP-HPLC method for Acyclovir determination in tablet and cream dosage forms. Drug Discovery. 2019: 13: 107-114.

27. Ghosh S. Sahu A. Kumar DS. Jena S. Harani A. Reddy TPK. Tanuja D. Method development and validation for acyclovir in tablet dosage form by RP-HPLC. Journal of Pharmacy Research. 2012: 5(3): 1785-1786.

28. Mule SG. Patre NG. Kshirsagar AD. Kharwade SB. The Estimation of Acyclovir in Bulk and Tablet Dosage form by Using Specificity and Analytical Method Development. Acta Scientific Pharmaceutical Sciences. 2022: 6(3): 9-12.

29. Manoharan G. Mohamed RAW. Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Aciclovir in Bulk and Ointment Dosage Form. International Journal of Pharmaceutical and Phytopharmacological Research. 2019: 9(1): 11-18.

30. Kumar CV. Kumar DA. Rao JVLNS. Development and Validation of Rp-Hplc Method for the Determination of Acyclovir in Human Plasma. International Journal of Chemical Science. 2010: 8(1): 475-482.

31. Muralidharan S. Kalaimani J. Parasuraman S. Dhanaraj SA. Development and Validation of Acyclovir HPLC External Standard Method in Human Plasma: Application to Pharmacokinetic Studies. Advances in Pharmaceutics. 2014: 1-5.

32. Ravisankar P. Niharika A. Sireesha S. Koushik OS. Himaja V. Development and Validation of Rp-Hplc Method for Quantitative Estimation of Acyclovir in Bulk Drug and Tablets. Journal of Chemical and Pharmaceutical Sciences. 2015: 8(1): 73-80

33. Dessai P. Fatrekar N. Stability Indicating Method Developmnt and Validation of Uv Method for the Determination of Acyclovir in Tablet Dosage Form. Indo American Journal of Pharmaceutical Sciences. 2018: 5(9): 8955-8960.

34. Lasure A. Ansari A. Kalshetti M. UV Spectrophotometric Analysis and Validation of Acyclovir in Solid Dosage Form, International Journal of Current Pharmaceutical Research. 2020:12(2):100-103

35. Paul D. Sanap G. Shenoy S. Kalyane D. Kalia K. Tekade RK. Artificial intelligence in drug discovery and development. Drug Discovery Today. 2021: 26(1): 80-93. doi: 10.1016/j.drudis.2020.10.010

36. Jang IJ. Artificial intelligence in drug development: clinical pharmacologist perspective. Translational and Clinical Pharmacology. 2019: 27(3): 87-88. doi: 10.12793/tcp.2019.27.3.87.

37. Hughes JP. Rees S. Kalindjian SB. Philpott KL. Principles of early drug discovery. British Journal of Pharmacology. 2011: 162(6): 1239-49. doi: 10.1111/j.1476-5381.2010.01127.x

38. Pramod K. Tahir MA. Charoo NA. Ansari SH. Ali J. Pharmaceutical product development: A quality by design approach. International Journal of Pharmaceutical Investigation. 2016: 6(3):129-38. doi: 10.4103/2230-973X.187350

39. Popkin ME. Goese M. Wilkinson D. Finnie S. Flanagan T. Campa C. Clinch A. Teasdale A. Lennard A. Cook G. Mohan G. Osborne MD. Chemistry Manufacturing and Controls Development. Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines. American Association of Pharmaceutical Scientists. 2022: 24(6): 101. doi: 10.1208/s12248-022-00751-9

40. Marquerita Algorri. Nina S. Cauchon. Michael J. Abernathy. Transitioning Chemistry, Manufacturing, and Controls Content With a Structured Data Management Solution: Streamlining Regulatory Submissions. Journal of Pharmaceutical Sciences. 2020 :109(4): 1427-1438

41. Chiodin D. Cox EM. Edmund AV. Kratz E. Lockwood SH. Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications. Clinical and Translational Science. 2019: 12(4): 334-342. doi: 10.1111/cts.12635.

42. Samara C. Garcia A. Henry C. Vallotton L. Cariolato L. Desmeules J. Pincon A. Safety Surveillance During Drug Development: Comparative Evaluation of Existing Regulations. Advances in Therapy. 2023: 40(5): 2147-2185. doi: 10.1007/s12325-023-02492-3.

43. Yao B. Zhu L. Jiang Q. Xia HA. Safety monitoring in clinical trials. Pharmaceutics. 2013: 5(1): 94-106. doi: 10.3390/pharmaceutics5010094

44. Balamurugan Krishnan. Kirtimaya Mishra. Quality by Design based Development and Validation of RP-HPLC Method for Simultaneous Estimation of Sitagliptin and Metformin in Bulk and Pharmaceutical Dosage Forms. International Journal of Pharmaceutical Investigation. 2020: 10(4): 512-518.

45. Lorrene A. Buckley. Ilona Bebenek. Paul D. Cornwell. Aimee Hodowanec. Eric C. Jensen. Caitlin Murphy and Hanan N. Ghantous, Drug Development 101: A Primer. 2020: 39(5): 365-495

46. Krishnan Balamurugan. Kirtimaya Mishra. Optimization and Validation of the Simultaneous Determination of Vildagliptin and Metformin, in Bulk and Formulation by A Reverse Phase HPLC Method Using D-Optimal Experimental Design. Journal of Global Pharma Technology. 2020: 12(8): 1-12.

47. Azadeh M. Sondag P. Wang Y. Raines M. Sailstad J. Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot to Lot Consistency, and Prevention of Assay Drift. American Association of Pharmaceutical Scientists. 2019: 21(5): 89. doi: 10.1208/s12248-019-0354-6

48. Song JG. Baral KC. Kim GL. Park JW. Seo SH. Kim DH. Jung DH. Ifekpolugo NL. Han HK. Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques. Drug Delivery. 2023: 30(1): 2183816. doi: 10.1080/10717544.2023.2183816

49. M Rajavardhan Reddy. Kirtimaya Mishra. R Suresh. Development and Validation of a Liquid Chromatographic Method for the Determination of Selected Anti Cancer Drugs in Bulk and Pharmaceutical Formulations. International Journal of Pharma Research and Health Sciences. 2018: 6(1): 2303-07.

50. Cortese M. Gigliobianco MR. Magnoni F. Censi R. Di Martino PD. Compensate for or Minimize Matrix Effects? Strategies for Overcoming Matrix Effects in Liquid Chromatography-Mass Spectrometry Technique: A Tutorial Review. Molecules. 2020: 25(13): 3047. doi: 10.3390/molecules25133047

51. Kevin D. Clark. Cheng Zhang and Jared L. Anderson. Sample Preparation for Bioanalytical and Pharmaceutical Analysis. 2016: 88(23): 11262-11270.

52. Yogesh K. Dwivedi. Anuj Sharma. Nripendra P. Rana. Mihalis Giannakis. Pooja Goel. Vincent Dutot. Evolution of artificial intelligence research in Technological Forecasting and Social Change: Research topics, trends, and future directions. Technological Forecasting and Social Change. 2023: 192: 122579.

53. Park G. Kim MK. Go SH. Choi M. Jang YP. Analytical Quality by Design (AQbD) Approach to the Development of Analytical Procedures for Medicinal Plants. Plants (Basel). 2022: 11(21): 2960. doi: 10.3390/plants11212960

54. Jaiprakash N. Sangshetti. Mrinmayee Deshpande. Zahid Zaheer. Devanand B. Shinde. Rohidas Arote. Quality by design approach: Regulatory need. Arabian Journal of Chemistry. 2017: 10(supplement 2): S3412-S3425

55. Gutierrez L. Cauchon NS. Christian TR. Giffin MJ. Abernathy MJ. The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations. Journal of Pharmaceutical Sciences. 2020: 109(12): 3524-3534. doi: 10.1016/j.xphs.2020.09.025

56. Nupur N. Joshi S. Gulliarme D. Rathore AS. Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms. Frontiers in Bioengineering and Biotechnology. 2022: 10: 832059. doi: 10.3389/fbioe.2022.832059

57. Vora LK. Gholap AD. Jetha K. Thakur RRS. Solanki HK. Chavda VP. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics. 2023: 15(7): 1916. doi: 10.3390/pharmaceutics15071916

58. Olga Kapustina. Polina Burmakina. Nina Gubina. Nikita Serov. Vladimir Vinogradov. User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals. Artificial Intelligence Chemistry. 2024: 2(2): 100072

59. Sampene, A.K. Nyirenda. F. Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China. Future Journal of Pharmaceutical Sciences. 2024: 10(58). https://doi.org/10.1186/s43094-024-00632-2

60. Lei Yin. Luyao Yu. Yingxia Guo. Chuya Wang. Yuncheng Ge. Xinyue Zheng. Ning Zhang. Jiansong You. Yong Zhang. Meiyun Shi. Green analytical chemistry metrics for evaluating the greenness of analytical procedures. Journal of Pharmaceutical Analysis. 2024: 101013

Received on 06.06.2025 Revised on 14.12.2025

Accepted on 08.04.2026 Published on 16.04.2026

Available online from April 18, 2026

Asian Journal of Pharmaceutical Analysis. 2026; 16(2):128-136.

DOI: 10.52711/2231-5675.2026.00020

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

Drug	Structure	IUPAC Name	Molecular weight	Solubility
Abacavir		{(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopenten-1-yl} methanol	322.79 g/mol	Easily dissolved in methanol, ethanol, and water
Adefovir dipivoxil		2-(6-aminopurin-9-yl) ethoxymethylphosphonic acid	273.19 g/mol	Soluble in ethanol, methanol, water
Cidofovir anhydrous drug		[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan -2 - yl] oxymethylphosphonic-acid	279.19 g/mol	Soluble in organic solvents such as ethanol, DMSO
AVR (Zovirax)		2-amino-9-(2- hydroxyethoxymethyl)-1H- purin-6-one	225.21 g/mol	Easily dissolved in ethanol and DSMO, minimally soluble in water
Entecavir (Baraclude)		2-amino-9-[(1S,3R,4S)-4- hydroxy-3-(hydroxy-methyl)-2- methylidene-cyclopentyl]-1H- purin-6-one	277.279g/mol	Easily dissolved in organic solvents like ethanol, DMSO, DMF and slightly soluble in water
Famciclovir (Famvir)		[2-(acetyloxy-methyl)-4-(2-amino-purin-9-yl)-butyl] acetate	321.332g/mol	Barely soluble in ethanol and isopropanol and freely soluble in acetone and methanol
Tenofovir anhydrous		[(2R)-1-(6-amino-purin-9-yl)-propan-2-yl]-oxymethyl-phosphonic acid	287.213g/ mol	Soluble in DMSO, methanol, water and ethanol
Remdesivir (Veklury)		2-ethyl-butyl-(2S)-2-[[[(2R,3S,4R,5R)-5-(4-amino-pyrrole-[2,1-f][1,2,4]-triazin-7-yl)-5-cyano-3,4-dihydroxy-oxolan-2-yl]-methoxy-phenoxy-phosphoryl]-amino]-propanoate	602.585g/mol	Easily dissolved in organic solvents like ethanol, DMSO, DMF and lightly soluble in water
Sofosbuvir (Sovaldi)		(S)-Isopropyl 2-((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl) methoxy)-(phenoxy) phosphorylamino) propanoate	529.453g/mol	It is insoluble in heptane, soluble in 2-propanol, easily dissolve in ethanol and acetone, and slightly dissolved in water.